Links between Vitamin D deficiency and cardiovascular diseases

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Mozos, Ioana ^a   Marginean, Otilia ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

AGING; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL STIFFNESS; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; BLOOD VESSEL CALCIFICATION; CALCIUM METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL GROWTH; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FOAM CELL; GLYCEMIC CONTROL; GROWTH INHIBITION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INSULIN RELEASE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; LIPID METABOLISM; METABOLIC SYNDROME X; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SECONDARY HYPERPARATHYROIDISM; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE CELL; VASCULITIS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; CARDIOVASCULAR DISEASES; COMPLICATION; KIDNEY; METABOLISM; PATHOLOGY;

CARDIOVASCULAR DISEASES; HUMANS; KIDNEY; METABOLIC SYNDROME X; RENIN-ANGIOTENSIN SYSTEM; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84929358911     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/109275     Document Type: Review

References (134)

1. J. H. Lee, J. H. O'Keefe,D. Bell, D. D. Hensrud, and M. F. Holick, "Vitamin D deficiency. An important, common, and easily treatable cardiovascular risk factor?" Journal of the American College of Cardiology, vol. 52, no. 24, pp. 1949-1956, 2008.
2. I. Al Mheid, R. S. Patel, V. Tangpricha, and A. A. Quyyumi, "Vitamin D and cardiovascular disease: Is the evidence solid?" European Heart Journal, vol. 34, no. 48, pp. 3691-3698, 2013.
3. D. Somjen, Y. Weisman, F. Kohen et al. , "25-Hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds," Circulation, vol. 111, no. 13, pp. 1666-1671, 2005.
4. C. Zhou, F. Lu, K. Cao, D. Xu, D. Goltzman, and D. Miao, "Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1-hydroxylase knockout mice," Kidney International, vol. 74, no. 2, pp. 170-179, 2008.
5. J. S. Adams and M. Hewison, "Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase," Archives of Biochemistry and Biophysics, vol. 523, no. 1, pp. 95-102, 2012.
6. R. Chowdhury, S. Kunutsor, A. Vitezova et al. , "Vitamin D and risk of cause specific death: Systematic reviewandmeta-analysis of observational cohort and randomised intervention studies," British Medical Journal, vol. 348, Article IDg1903, 2014.
7. P. E. Norman and J. T. Powell, "Vitamin D and cardiovascular disease," Circulation Research, vol. 114, no. 2, pp. 379-393, 2014.
8. L. Wang, J. Ma, J. E. Manson, J. E. Buring, J. M. Gaziano, and H. D. Sesso, "A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men," European Journal of Nutrition, vol. 52, no. 7, pp. 1771-1779, 2013.
9. J. H. Lee, R. Gadi, J. A. Spertus, F. Tang, and J. H. O'Keefe, "Prevalence of vitamin D deficiency in patients with acute myocardial infarction,"The American Journal of Cardiology, vol. 107, no. 11, pp. 1636-1638, 2011.
10. R. Patel and A. A. Rizvi, "Vitamin D deficiency in patients with congestive heart failure: Mechanisms, manifestations, and management," SouthernMedical Journal, vol. 104, no. 5,pp. 325-330, 2011.
11. V. Kunadian, G. A. Ford, B. Bawamia,W. Qiu, and J. E. Manson, "Vitamin D deficiency and coronary artery disease: A review of the evidence," American Heart Journal, vol. 167, no. 3, pp. 283-291, 2014.
12. T. J. Wang, M. J. Pencina, S. L. Booth et al. , "Vitamin D deficiency and risk of cardiovascular disease," Circulation, vol. 117, no. 4, pp. 503-511, 2008.
13. A. Zittermann and S. Prokop, "The role of vitamin D for cardiovascular disease and overall mortality," Advances in Experimental Medicine and Biology, vol. 810, pp. 106-119, 2014.
14. K. D. Cashman, "A review of vitamin D status and CVD," Proceedings of the Nutrition Society, vol. 73, no. 1, pp. 65-72, 2014.
15. H. A. Bischoff-Ferrari, E. Giovannucci,W. C. Willett et al. , "Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes," The American Journal of Clinical Nutrition, vol. 84, pp. 18-28, 2006.
16. M. F. Holick and T. C. Chen, "Vitamin D deficiency: A worldwide problemwith health consequences," The American Journal of ClinicalNutrition, vol. 87,no. 4, supplement,pp. 1080S-1086S, 2008.
17. Institute ofMedicine, Dietary Reference Intakes for Calciumand Vitamin D, The National Academies Press, Washington, DC, USA, 2011.
18. A. Zittermann, S. Iodice, S. Pilz, W. B. Grant, V. Bagnardi, and S. Gandini, "Vitamin D deficiency and mortality risk in the general population: A meta-analysis of prospective cohort studies,"The American Journal of Clinical Nutrition, vol. 95, no. 1, pp. 91-100, 2012.
19. Y. C. Li, J. Kong, M. Wei, Z.-F. Chen, S. Q. Liu, and L.-P. Cao, "1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system," The Journal of Clinical Investigation, vol. 110, no. 2, pp. 229-238, 2002.
20. H. Tamez, S. Kalim, and R. I. Thadhani, "Does vitamin D modulate blood pressure?" Current Opinion in Nephrology and Hypertension, vol. 22, no. 2, pp. 204-209, 2013.
21. Y. C. Li, "VitaminDregulation of the renin-angiotensin system," Journal of Cellular Biochemistry, vol. 88,no. 2, pp. 327-331, 2003.
22. J. Dong, S. L. Wong, C. W. Lau et al. , "Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress," European Heart Journal, vol. 33, no. 23, pp. 2980-2990, 2012.
23. J. M. Smith,D. R. Mouw, and A. J. Vander, "Effect of parathyroid hormone on renin secretion," Proceedings of the Society for Experimental Biology and Medicine, vol. 172, no. 4, pp. 482-487, 1983.
24. P. D. Broulik, K. Horky, and V. Pacovsky, "Effect of parathyroid hormone on plasma renin activity in humans," Hormone and Metabolic Research, vol. 18, no. 7, pp. 490-492, 1986.
25. M. Ferder, F. Inserra, W. Manucha, and L. Ferder, "The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the reninangiotensin system," The American Journal of Physiology-Cell Physiology, vol. 304, no. 11, pp. C1027-C1039, 2013.
26. C. Wang, "Role of vitamin D in cardiometabolic diseases," Journal of Diabetes Research, vol. 2013, Article ID 243934, 10 pages, 2013.
27. S. E. Judd and V. Tangpricha, "Vitamin D deficiency and risk for cardiovascular disease," The American Journal of theMedical Sciences, vol. 338, no. 1, pp. 40-44, 2009.
28. M. C. Cure, E. Cure, S. Yuce, T. Yazici, I. Karakoyun, and H. Efe, "Mean platelet volume and vitamin D level," Annals of Laboratory Medicine, vol. 34, no. 2, pp. 98-103, 2014.
29. S. Pilz, M. Gaksch, B. O'Hartaigh, A. Tomaschitz, and W. März, "The role of vitamin D deficiency in cardiovascular disease: Where do we stand in 2013?" Archives of Toxicology, vol. 87, no. 12, pp. 2083-2103, 2013.
30. P. E. Norman and J. T. Powell, "VitaminD, shedding light on the development of disease in peripheral arteries," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 1, pp. 39-46, 2005.
31. J. Oh, S. Weng, S. K. Felton et al. , "1,25(OH)2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus," Circulation, vol. 120, no. 8, pp. 687-698, 2009.
32. K. C. Maki, M. R. Rubin, L. G. Wong et al. , "Serum 25-hydroxyvitamin D is independently associated with highdensity lipoprotein cholesterol and the metabolic syndrome in men and women," Journal of Clinical Lipidology, vol. 3, no. 4, pp. 289-296, 2009.
33. T. D. O'Connell, J. E. Berry, A. K. Jarvis,M. J. Somerman, and R. U. Simpson, "1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 272, no. 4, pp. H1751-H1758, 1997.
34. M. R. Davies and K. A. Hruska, "Pathophysiological mechanisms of vascular calcification in end-stage renal disease," Kidney International, vol. 60, no. 2, pp. 472-479, 2001.
35. W. F. C. Rigby, S. Denome, and M. W. Fanger, "Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA," Journal of Clinical Investigation, vol. 79, no. 6, pp. 1659-1664, 1987.
36. M. O. Canning, K. Grotenhuis, H. de Wit, C. Ruwholf, and H. A. Drexhage, "1-,25-dihydroxyvitamin D3 (1,25(OH)2D3) hampers the maturation of fully active immature dendritic cells from monocytes," European Journal of Endocrinology, vol. 145, no. 3, pp. 351-357, 2001.
37. K.-I. Aihara, H. Azuma,M. Akaike et al. , "Disruptionofnuclear vitamin D receptor gene causes enhanced thrombogenicity in mice," Journal of Biological Chemistry, vol. 279, no. 34, pp. 35798-35802, 2004.
38. X. Guillot, L. Semerano, N. Saidenberg-Kermanac'h, G. Falgarone, and M.-C. Boissier, "Vitamin D and inflammation," Joint Bone Spine, vol. 77, no. 6, pp. 552-557, 2010.
39. M. Takeda, T. Yamashita, N. Sasaki et al. , "Oral administration of an active form of vitamin D3 (Calcitriol) decreases atherosclerosis in mice by inducing regulatory t cells and immature dendritic cells with tolerogenic functions," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30,no. 12, pp. 2495-2503, 2010.
40. J. E. Manson, S. S. Bassuk, I.-M. Lee et al. , "The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease," Contemporary Clinical Trials, vol. 33, no. 1, pp. 159-171, 2012.
41. D. Martins, M. Wolf,D. Pan et al. , "Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: Data from the Third National Health and Nutrition Examination Survey," Archives of Internal Medicine, vol. 167, no. 11, pp. 1159-1165, 2007.
42. N. Aggarwal, J. P. Reis, and E. D. Michos, "Vitamin D deficiency and its implications on cardiovascular disease," Current Cardiovascular Risk Reports, vol. 4, no. 1, pp. 68-75, 2010.
43. S. U. Nigwekar and R. Thadhani, "Vitamin D receptor activation: Cardiovascular and renal implications," Kidney International Supplements, vol. 3, no. 5, pp. 427-430, 2013.
44. S. Pilz, A. Tomaschitz, E. Ritz, and T. R. Pieber, "Vitamin D status and arterial hypertension: A systematic review," Nature Reviews. Cardiology, vol. 6, no. 10, pp. 621-630, 2009.
45. J. Almirall, M. Vaquerlo, M. L. Bare et al. , "Association of low serum 25-hydroxyvitamin D levels and high arterial blood pressure in the elderly," Nephrology Dialysis Transplantation, vol. 25, pp. 503-509, 2010.
46. K. G. McCarroll, D. J. Robinson, A. Coughlan, M. Healy, R. A. Kenny, and C. Cunningham, "Vitamin D and orthostatic hypotension," Age and Ageing, vol. 41, no. 6, pp. 810-813, 2012.
47. L. M. Resnick, F. B. Muller, and J. H. Laragh, "Calciumregulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism," Annals of Internal Medicine, vol. 105, no. 5, pp. 649-654, 1986.
48. E. D. Burgess, R. G. Hawkins, and M. Watanabe, "Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension,"The American Journal of Hypertension, vol. 3, no. 12 I, pp. 903-905, 1990.
49. E. Kristal-Boneh, P. Froom, G. Harari, and J. Ribak, "Association of calcitriol and blood pressure in normotensive men," Hypertension, vol. 30, no. 5, pp. 1289-1294, 1997.
50. R. E. Weishaar and R. U. Simpson, "Vitamin D3 and cardiovascular function in rats,"The Journal of Clinical Investigation, vol. 79, no. 6, pp. 1706-1712, 1987.
51. S. Chen, C. S. Law, C. L. Grigsby et al. , "Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy," Circulation, vol. 124, no. 17, pp. 1838-1847, 2011.
52. N. Bodyak, J. C. Ayus, S. Achinger et al. , "Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 43, pp. 16810-16815, 2007.
53. S. G. Rostand, "Ultraviolet light may contribute to geographic and racial blood pressure differences," Hypertension, vol. 30, no. 2, pp. 150-156, 1997.
54. R. Krause, M. Bühring, W. Hopfenmüller, M. F. Holick, and A. M. Sharma, "Ultraviolet B and blood pressure," The Lancet, vol. 352, no. 9129, pp. 709-710, 1998.
55. L. Lind, B. Wengle, L. Wide, and S. Ljunghall, "Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status: A double-blind, placebo-controlled study," The American Journal of Hypertension, vol. 2, no. 1, pp. 20-25, 1989.
56. M. Pfeifer, B. Begerow, H. W. Minne, D. Nachtigall, and C. Hansen, "Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women," Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 4, pp. 1633-1637, 2001.
57. Y. Kimura, M. Kawamura, M. Owada et al. , "Effectiveness of 1, 25-dihydroxyvitamin D supplementation on blood pressure reduction in a pseudohypoparathyroidism patient with high renin activity," Internal Medicine, vol. 38, no. 1, pp. 31-35, 1999.
58. C.-M. Kim and Y.-S. Kim, "Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism," The American Journal of Kidney Diseases, vol. 33, no. 1, pp. 73-81, 1999.
59. E. Ergenekon, K. Gucüyener, H. Dursun et al. , "Nitric oxide production in newborns under phototherapy," Nitric Oxide-Biology and Chemistry, vol. 6, no. 1, pp. 69-72, 2002.
60. M. S. K. Wong, R. Delansorne, R. Y. K. Man, and P. M. Vanhoutte, "VitaminDderivatives acutely reduce endotheliumdependent contractions in the aorta of the spontaneously hypertensive rat," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 295, no. 1, pp. H289-H296, 2008.
61. C. Molinari, F. Uberti, E. Grossini et al. , "1,25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells," Cellular Physiology and Biochemistry, vol. 27, no. 6, pp. 661-668, 2011.
62. M. Grundmann, M. Haidar, S. Placzko et al. , "Vitamin D improves the angiogenic properties of endothelial progenitor cells," The American Journal of Physiology -Cell Physiology, vol. 303, no. 9, pp. C954-C962, 2012.
63. M. D. Witham, S. Ireland, J. Graeme Houston et al. , "Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: Randomized, controlled trial," Hypertension, vol. 63, no. 4, pp. 706-712, 2014.
64. L. M. Bodnar, J. M. Catov, H. N. Simhan, M. F. Holick, R. W. Powers, and J. M. Roberts, "Maternal vitamin D deficiency increases the risk of preeclampsia," Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 9, pp. 3517-3522, 2007.
65. S.-Q. Wei, H.-P. Qi, Z.-C. Luo, and W. D. Fraser, "Maternal vitamin D status and adverse pregnancy outcomes: A systematic review and meta-analysis," The Journal of Maternal-Fetal & Neonatal Medicine, vol. 26, no. 9, pp. 889-899, 2013.
66. C. J. Robinson, M. C. Alanis, C. L. Wagner, B. W. Hollis, and D. D. Johnson, "Plasma 25-hydroxyvitamin D levels in earlyonset severe preeclampsia," The American Journal of Obstetrics and Gynecology, vol. 203, no. 4, pp. 366-e6, 2010.
67. N. Nassar, G. H. Halligan, C. L. Roberts, J. M. Morris, and A. W. Ashton, "Systematic review of first-trimester vitamin D normative levels and outcomes of pregnancy," The American Journal of Obstetrics and Gynecology, vol. 205, no. 3, pp. 208. e1-208. e7, 2011.
68. F. J. Schneuer, C. L. Roberts, C. Guilbert et al. , "Effects of maternal serum 25-hydroxyvitamin D concentrations in the first trimester on subsequent pregnancy outcomes in an Australian population1-3,"The American Journal of Clinical Nutrition, vol. 99, no. 2, pp. 287-295, 2014.
69. A. C. Staff, B. M. Sibai, and F. G. Cunningham, "Prevention of preeclampsia and eclampsia," in Chesley's Hypertensive Disorders in Pregnancy, pp. 213-225, Elsevier, 2015.
70. S. Dluholucký, B. Frčová, and F. Hrubá, "Relation of blood pressure values in thirteen-years old adolescents to themode of vitamin D prophylaxis during their infancy," NeuroEndocrinology Letters, vol. 34, no. 6, pp. 518-522, 2013.
71. P. Soysal, A. Yay, and A. T. Isik, "Does vitamin D deficiency increase orthostatic hypotension risk in the elderly patients?" Archives of Gerontology and Geriatrics, vol. 59, no. 1, pp. 74-77, 2014.
72. M. F. Holick, "Vitamin D deficiency,"The New England Journal of Medicin, vol. 357, pp. 266-281, 2007.
73. K. L. Margolis, R. M. Ray, L. vanHorn et al. , "Effect of calcium and vitaminDsupplementation on blood pressure: The women's health initiative randomized trial," Hypertension, vol. 52, no. 5, pp. 847-855, 2008.
74. F. Carbone, F. Mach, N. Vuilleumier, and F. Montecucco, "Potential pathophysiological role for the vitamin D deficiency in essential hypertension," World Journal of Cardiology, vol. 6, no. 5, pp. 260-276, 2014.
75. M. B. Snijder, P. Lips, J. C. Seidell et al. , "Vitamin D status and parathyroid hormone levels in relation to blood pressure: A population-based study in older men and women," Journal of Internal Medicine, vol. 261, no. 6, pp. 558-565, 2007.
76. K. Kienreich, A. Tomaschitz,N. Verheyen et al. , "VitaminDand cardiovascular disease," Nutrients, vol. 5, no. 8, pp. 3005-3021, 2013.
77. L. Lind, A. Hanni, H. Lithell, A. Hvarfner,O. H. Sorensen, and S. Ljunghall, "Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men," The American Journal of Hypertension, vol. 8, no. 9, pp. 894-901, 1995.
78. D. S. Grimes, "Are statins analogues of vitamin D?" The Lancet, vol. 368, no. 9529, pp. 83-86, 2006.
79. J. L. Pérez-Castrillón, G. Vega, L. Abad et al. , "Effects of atorvastatin on vitamin D levels in patients with acute ischemic heart disease," The American Journal of Cardiology, vol. 99, no. 7, pp. 903-905, 2007.
80. J. Wortsman, L. Y. Matsuoka, T. C. Chen, Z. Lu, and M. F. Holick, "Decreased bioavailability of vitamin D in obesity," The American Journal of Clinical Nutrition, vol. 72, no. 3, pp. 690-693, 2000.
81. T. Takiishi,C. Gysemans, R. Bouillon, and C. Mathieu, "Vitamin D and diabetes," Endocrinology and Metabolism Clinics of North America, vol. 39, no. 2, pp. 419-446, 2010.
82. P. Knekt, M. Laaksonen, C. Mattila et al. , "Serumvitamin D and subsequent occurrence of type 2 diabetes," Epidemiology, vol. 19, no. 5, pp. 666-671, 2008.
83. N. G. Forouhi, Z. Ye, A. P. Rickard et al. , "Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: Results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of Prospective studies," Diabetologia, vol. 55, no. 8, pp. 2173-2182, 2012.
84. K. Tai, A. G. Need,M. Horowitz, and I. M. Chapman, "Vitamin D, glucose, insulin, and insulin sensitivity," Nutrition, vol. 24, no. 3, pp. 279-285, 2008.
85. F. Oz, A. Y. Cizgici, H. Oflaz et al. , "Impact of vitamin D insufficiency on the epicardial coronary flow velocity and endothelial function," Coronary Artery Disease, vol. 24, no. 5, pp. 392-397, 2013.
86. S. Rocchiccioli, M. G. Andreassi, A. Cecchettini, C. Carpeggiani, A. L'Abbate, and L. Citti, "Correlation between vitamin D binding protein expression and angiographic-proven coronary artery disease," Coronary Artery Disease, vol. 23, no. 7, pp. 426-431, 2012.
87. S. M. Hlaing, L. A. Garcia, J. R. Contreras et al. , "1,25-vitamin D3 promotes cardiac differentiation through modulation of the WNT signaling pathway," Journal of Molecular Endocrinology, vol. 53, no. 3, pp. 303-317, 2014.
88. B. Goleniewska, M. Kacprzak, and M. Zielińska, "Vitamin D level and extent of coronary stenotic lesions in patientswith first acute myocardial infarction," Cardiology Journal, vol. 21, no. 1, pp. 18-23, 2014.
89. L. L. Ng, J. K. Sandhu, I. B. Squire, J. E. Davies, and D. J. L. Jones, "Vitamin D and prognosis in acute myocardial infarction," International Journal of Cardiology, vol. 168, no. 3, pp. 2341-2346, 2013.
90. L. C. Correia, F. Sodre, G. Garcia et al. , "Relation of severe deficiency of vitamin D to cardiovascular mortality during acute coronary syndromes," American Journal of Cardiology, vol. 111, no. 3, pp. 324-327, 2013.
91. F. Akin, B. Ayca, N. Kose et al. , "Serum vitamin D levels are independently associated with severity of coronary artery disease," Journal of InvestigativeMedicine, vol. 60,no. 6, pp. 869-873, 2012.
92. Y. Arnson, D. Itzhaky,M. Mosseri et al. , "Vitamin D inflammatory cytokines and coronary events: A comprehensive review," Clinical Reviews in Allergy and Immunology, vol. 45, no. 2, pp. 236-247, 2013.
93. C. Robinson-Cohen, A. N. Hoofnagle, J. H. Ix et al. , "Racial differences in the association of serum 25-hydroxyvitamin D concentrationwith coronary heart disease events," Journal of the American Medical Association, vol. 310, no. 2, pp. 179-188, 2013.
94. S. Pilz, R. M. A. Henry, M. B. Snijder et al. , "Vitamin D deficiency and myocardial structure and function in older men and women: The Hoorn study," Journal of Endocrinological Investigation, vol. 33, no. 9, pp. 612-617, 2010.
95. A. Pandit, F. Mookadam, S. Boddu et al. , "Vitamin D levels and left ventricular diastolic function," OpenHeart, vol. 1, no. 1, 2014.
96. S. P. Laguardia, B. K. Dockery, S. K. Bhattacharya, M. D. Nelson, L. D. Carbone, and K. T. Weber, "Secondary hyperparathyroidism and hypovitaminosis D in African-Americans with decompensated heart failure,"The American Journal of the Medical Sciences, vol. 332, no. 3, pp. 112-118, 2006.
97. M. Sobieszczánska, J. Jonkisz, M. Tabin, and K. Laszki-Szcząchor, "Osteoporosis: Genetic determinants and relationship with cardiovascular disease," Advances in Clinical and Experimental Medicine, vol. 22, no. 1, pp. 119-124, 2013.
98. S. Bae, S. S. Singh, H. Yu, J. Y. Lee, B. R. Cho, and P. M. Kang, "Vitamin D signaling pathway plays an important role in the development of heart failure aftermyocardial infarction," Journal of Applied Physiology, vol. 114, no. 8, pp. 979-987, 2013.
99. J. A. Ford, G. S. MacLennan, A. Avenell et al. , "Cardiovascular disease and vitamin D supplementation: Trial analysis, systematic review, and meta-analysis,"The American Journal of Clinical Nutrition, vol. 100, no. 3, pp. 746-755, 2014.
100. A. Rahman, S. Hershey, S. Ahmed, K. Nibbelink, and R. U. Simpson, "Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice," Journal of Steroid Biochemistry and Molecular Biology, vol. 103, no. 3-5, pp. 416-419, 2007.
101. J. N. Artaza and K. C. Norris, "VitaminDreduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells," Journal of Endocrinology, vol. 200, no. 2, pp. 207-221, 2009.
102. M. S. K. Wong, R. Delansorne, R. Y. K. Man, P. Svenningsen, and P. M. Vanhoutte, "Chronic treatment with vitaminDlowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat," American Journal of Physiology-Heart and Circulatory Physiology, vol. 299, no. 4, pp. H1226-H1234, 2010.
103. J. Merke, P. Milde, S. Lewicka et al. , "Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries," The Journal of Clinical Investigation, vol. 83, no. 6, pp. 1903-1915, 1989.
104. H. W. Kim, C. W. Park, Y. S. Shin et al. , "Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis," Nephron-Clinical Practice, vol. 102, no. 1, pp. C21-C29, 2006.
105. V. Savica, G. Bellinghieri, P. Monardo, U. Muraca, and D. Santoro, "An update on calcium metabolism alterations and cardiovascular risk in patients with chronic kidney disease: Questions, myths and facts," Journal of Nephrology, vol. 26, no. 3, pp. 456-464, 2013.
106. D. Santoro, S. Lucisano, G. Gagliostro et al. , "Vitamin D receptor polymorphism in chronic kidney disease patients with complicated cardiovascular disease," Journal of Renal Nutrition, 2014.
107. M. Demir, U. Uyan, and M. Melek, "The effects of vitamin D deficiency on atrial fibrillation," Clinical and AppliedThrombosis/ Hemostasis, vol. 20, no. 1, pp. 98-103, 2014.
108. W. R. Chen, Z. Y. Liu, Y. Shi et al. , "Relation of low vitamin D to nonvalvular persistent atrial fibrillation in Chinese patients," Annals of Noninvasive Electrocardiology, vol. 19, no. 2, pp. 166-173, 2014.
109. D. A. Hanafy, S. L. Chang, Y. Y. Lu et al. , "Electromechanical effects of 1,25-dihydroxyvitamin d with antiatrial fibrillation activities," Journal of Cardiovascular Electrophysiology, vol. 25, no. 3, pp. 317-323, 2014.
110. M. Rienstra, S. Cheng, M. G. Larson et al. , "Vitamin D status is not related to development of atrial fibrillation in the community," The American Heart Journal, vol. 162, no. 3, pp. 538-541, 2011.
111. K. Kienreich, M. Grübler, A. Tomaschitz et al. , "Vitamin D, arterial hypertension & cerebrovascular disease," Indian Journal of Medical Research, vol. 137, no. 4, pp. 669-679, 2013.
112. E. Theodoratou, I. Tzoulaki, L. Zgaga, and J. P. A. Ioannidis, "Vitamin D and multiple health outcomes: Umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials," BritishMedical Journal, vol. 348, Article ID g2035, 2014.
113. S. Pilz, A. Tomaschitz, C. Drechsler, A. Zittermann, J. M. Dekker, and W. März, "Vitamin d supplementation: A promising approach for the prevention and treatment of strokes," Current Drug Targets, vol. 12, no. 1, pp. 88-96, 2011.
114. K. M. van de Luijtgaarden, M. T. Voûte, S. E. Hoeks et al. , "Vitamin D deficiency may be an independent risk factor for arterial disease," European Journal of Vascular and Endovascular Surgery, vol. 44, no. 3, pp. 301-306, 2012.
115. M. M. McDermott, K. Liu, L. Ferrucci et al. , "Vitamin D status, functional decline, and mortality in peripheral artery disease," Vascular Medicine, vol. 19, no. 1, pp. 18-26, 2014.
116. J. A. Kempker, V. Tangpricha, T. R. Ziegler, and G. S. Martin, "Vitamin D in sepsis: From basic science to clinical impact," Critical Care, vol. 16, no. 4, p. 316, 2012.
117. B. Lanske and M. S. Razzaque, "Mineral metabolism and aging: The fibroblast growth factor 23 enigma," Current Opinion in Nephrology and Hypertension, vol. 16, no. 4, pp. 311-318, 2007.
118. J. A. Reynolds, S. Haque, J. L. Berry et al. , "25-hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus," Rheumatology (Oxford), vol. 51, no. 3, pp. 544-551, 2012.
119. O. H. Ryu, W. Chung, S. Lee et al. , "The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes," The Korean Journal of Internal Medicine, vol. 29, no. 5, pp. 620-629, 2014.
120. W. Noonan, K. Koch, M. Nakane et al. , "Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats," Nephrology Dialysis Transplantation, vol. 23, no. 12, pp. 3824-3830, 2008.
121. A. Zittermann, S. S. Schleithoff, and R. Koerfer, "Vitamin D and vascular calcification," CurrentOpinion in Lipidology, vol. 18,no. 1, pp. 41-46, 2007.
122. S. E. Huether and K. L. McCance, Understanding Pathophysiology, Elsevier Mosby, St. Louis, Mo, USA, 5th edition, 2012.
123. M. S. Razzaque, "The dualistic role of vitamin D in vascular calcifications," Kidney International, vol. 79, no. 7, pp. 708-714, 2011.
124. S. Mathew, R. J. Lund, L. R. Chaudhary, T. Geurs, and K. A. Hruska, "Vitamin D receptor activators can protect against vascular calcification," Journal of the American Society of Nephrology, vol. 19, no. 8, pp. 1509-1519, 2008.
125. F. H. Mose, H. Vase, T. Larsen et al. , "Cardiovascular effects of cholecalciferol treatment in dialysis patients-A randomized controlled trial," BMC Nephrology, vol. 15, no. 1, article 50, 2014.
126. M. Wanic-Kossowska, P. Guzik, P. Lehman, and S. Czekalski, "Heart rate variability in patients with chronic renal failure treated by hemodialysis," Polskie Archiwum Medycyny Wewnetrznej, vol. 114, no. 3, pp. 855-861, 2005.
127. A. Testa, F. Mallamaci, F. A. Benedetto et al. , "Vitamin D Receptor (VDR) gene polymorphism is associated with Left Ventricular (LV) mass and predicts Left Ventricular Hypertrophy (LVH) progression in End-Stage Renal Disease (ESRD) patients," Journal of Bone and Mineral Research, vol. 25, no. 2, pp. 313-319, 2010.
128. A. M. El-Shehaby, M. M. El-Khatib, S. Marzouk, and A. A. Battah, "Relationship of BsmI polymorphism of vitamin D receptor gene with left ventricular hypertrophy and atherosclerosis in hemodialysis patients," Scandinavian Journal of Clinical & Laboratory Investigation, vol. 73, no. 1, pp. 75-81, 2013.
129. D. Santoro, G. Gagliostro, A. Alibrandi et al. , "Vitamin D receptor gene polymorphism and left ventricular hypertrophy in chronic kidney disease," Nutrients, vol. 6, no. 3,pp. 1029-1037, 2014.
130. M. P. Marco, L. Craver, A. Betriu, J. Fibla, and E. Fernández, "Influence of vitamin D receptor gene polymorphisms on mortality risk in hemodialysis patients," The American Journal of Kidney Diseases, vol. 38, no. 5, pp. 965-974, 2001.
131. G. P. Levin, C. Robinson-Cohen, I. H. de Boer et al. , "Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes," JAMA-Journal of the American Medical Association, vol. 308, no. 18, pp. 1898-1905, 2012.
132. B. Debreceni and L. Debreceni, "Role of vitamins in cardiovascular health and disease," Research Reports in Clinical Cardiology, no. 5, pp. 283-295, 2014.
133. M. J. Glade, "Vitamin D: Health panacea or false prophet?" Nutrition, vol. 29, no. 1, pp. 37-41, 2013.
134. M. J. Bolland, A. Grey, A. Avenell, G. D. Gamble, and I. R. Reid, "Calcium supplements with or without vitamin D and risk of cardiovascular events: Reanalysis of theWomen's Health Initiative limited access dataset and meta-analysis," British Medical Journal, vol. 342, no. 7804, Article IDd2040, 2011.